Overview
What Is Tesamorelin?
Tesamorelin is a synthetic peptide known as a growth-hormone-releasing hormone (GHRH) analog. In plain terms, it prompts your own pituitary gland to release growth hormone in a more natural, pulsatile pattern rather than introducing growth hormone directly.
It has drawn interest in longevity and body-composition medicine largely because of what research has explored about its effect on visceral adipose tissue — the deeper abdominal fat that wraps around organs and is closely tied to metabolic health.
At Protocol Health in Scarsdale, NY, Protocol Health offers tesamorelin through clinician-supervised care when appropriate, so we have a commercial interest in it and say so here. It is one of several peptides we may evaluate as part of an individualized, lab-informed plan — never a one-size-fits-all prescription. This article is educational and not medical advice; suitability is always determined case by case with a qualified provider.
Ask a Physician About TesamorelinQuick Answer
What Does Tesamorelin Do?
Tesamorelin signals the pituitary to release more of your body's own growth hormone, which in turn can raise IGF-1 and influence how the body handles fat and lean tissue. It has been studied most for its role in reducing visceral abdominal fat and supporting body composition.
Because it works upstream, the body's own feedback on growth hormone stays in play, which is the usual argument for it over direct growth hormone. Tesamorelin is a physician-supervised therapy that requires baseline labs and ongoing monitoring, not something to self-manage.
Mechanism
How Does Tesamorelin Work?
Tesamorelin works by mimicking the natural GHRH signal that tells your pituitary to release growth hormone. Your pituitary naturally secretes growth hormone in pulses, and that secretion tends to decline with age. Tesamorelin is a stabilized GHRH analog, meaning it mimics the natural signal that tells the pituitary to release growth hormone — but it is engineered to resist rapid breakdown in the body.
The downstream result can be a rise in growth hormone and IGF-1, the messenger that carries many of growth hormone's effects to tissues. This is thought to be why the peptide may influence fat metabolism, particularly visceral fat.
Because tesamorelin stimulates your own gland rather than flooding the system, the body's feedback loops remain part of the equation. This is a general mechanism description, not a promise of any specific outcome — individual response varies and is best assessed with a provider.
Benefits & Uses
What Are the Potential Benefits of Tesamorelin?
The potential benefits of tesamorelin center on its most studied application, the reduction of excess visceral abdominal fat. Research suggests it may help lower this deep fat depot, which matters because visceral fat is associated with metabolic and cardiovascular risk.
Some people ask about tesamorelin for general body composition or as part of a longevity strategy. Those uses have not been tested in large trials in people without HIV, so any benefit there is unproven and individual.
To be precise: tesamorelin is not a weight-loss shortcut and is not a substitute for medical weight-loss therapies like semaglutide or tirzepatide (which carry their own boxed warning about thyroid C-cell tumors and are not used with a personal or family history of medullary thyroid carcinoma or MEN 2). Where fat loss is a goal, a provider may consider it as one part of a larger plan that can include nutrition, training, and other treatments — always physician-supervised and individualized, with no guaranteed result.
The evidence
What did the tesamorelin trials show?
The tesamorelin trials show a drop in visceral fat, mainly in people with HIV who had built up that fat on antiretroviral therapy. In a 2007 New England Journal of Medicine trial, 412 patients received a daily 2 mg injection of tesamorelin or placebo for 26 weeks (Falutz et al., 2007). Visceral fat measured by CT fell 15.2% on tesamorelin and rose 5.0% on placebo. Triglycerides and the cholesterol-to-HDL ratio also improved, and IGF-1 rose 81%.
A pooled analysis of the two phase 3 trials, covering 806 patients, found a treatment effect of about 15.4% on visceral fat at 26 weeks, with no meaningful change in the fat just under the skin (Falutz et al., 2010). Patients who stayed on tesamorelin for 52 weeks kept the visceral fat reduction, and no clinically meaningful differences in glucose measures were seen versus placebo.
Two limits matter. These trials studied a specific population, adults with HIV and treatment-related abdominal fat, and the 2 mg daily dose is what the trials used, not a recommendation. Evidence in people without HIV is much thinner, so use for general body composition or longevity is off-label and should be framed that way by your provider. The trials also tested the approved drug, Egrifta; a compounded tesamorelin is a different product and is not FDA-approved.
Comparison
Tesamorelin vs sermorelin: what is the difference?
Tesamorelin and sermorelin both mimic GHRH, the hormone that tells the pituitary to release growth hormone. Sermorelin is a shorter fragment of the natural hormone. Tesamorelin is the full-length 44-amino-acid hormone with a chemical modification that helps it resist rapid breakdown.
The bigger practical difference is evidence. Tesamorelin has large randomized trials showing a visceral fat reduction in adults with HIV, which is how it earned FDA approval as Egrifta. Sermorelin has a longer clinical history but far less modern trial data for body composition. Which one fits depends on your goals, labs and history, and both require physician supervision. Protocol Health offers both, and a clinician decides at your peptide consultation which, if either, is appropriate; see sermorelin therapy for comparison.
Candidacy
Who Is a Candidate for Tesamorelin?
Good candidates are typically adults motivated by body-composition, metabolic, or longevity goals, who have completed appropriate labs and are cleared by a provider after a thorough review of their health history.
It may not be appropriate for everyone. People with certain conditions (including active malignancy, some pituitary disorders, or those who are pregnant or breastfeeding) are generally not candidates, and every case is screened individually.
Because tesamorelin sits within our hormone and longevity work, candidacy is often best explored through Protocol Health's male hormone and longevity assessment or female hormone and longevity assessment, which gives your clinician the full picture before any peptide is considered.
Safety
Is Tesamorelin Safe? Side Effects to Know
Tesamorelin was generally well tolerated in its phase 3 trials, but it is not side-effect free. In the 2007 NEJM trial, overall adverse events did not differ significantly from placebo, yet more patients on tesamorelin withdrew because of an adverse event. Injection-site reactions such as redness, itching or irritation are among the most commonly reported effects.
Other possible effects can include fluid retention, joint aches, tingling in the extremities, or changes in blood sugar, since growth hormone signaling can affect glucose handling. This is one reason ongoing monitoring and periodic labs matter.
Tesamorelin should only be used under the guidance of a qualified provider who can weigh your personal risks, review interactions, and monitor IGF-1 and metabolic markers over time. This educational overview is not a replacement for that individualized medical assessment.
The Experience
What Should You Expect from Treatment?
You should expect treatment to begin with a consultation and baseline labs so your clinician understands your hormones, metabolic health, and goals. From there, a provider determines whether tesamorelin is appropriate and how it fits your overall plan.
Tesamorelin is delivered by a small subcutaneous injection, and most protocols emphasize consistency over time. Follow-up visits and repeat labs are used to track response, adjust as needed, and confirm the therapy remains a good fit.
Any changes tend to develop gradually over weeks to months rather than overnight, and they vary from person to person. Your care team will set realistic, individualized expectations rather than promise a fixed outcome.
Our Approach
The Protocol Health Approach to Peptides
Protocol Health is a family-owned, physician-led clinic in Scarsdale, NY, seeing patients in person at the Scarsdale clinic and by telehealth in New York, New Jersey, Connecticut, Florida and California.
Every plan is individualized and lab-informed. A clinician reviews your history, screens for contraindications such as active cancer or pituitary disease, and monitors IGF-1 and glucose over time.
Tesamorelin is a modified GHRH that prompts your own growth hormone release, FDA-approved as Egrifta for visceral fat in adults with HIV, with much thinner evidence for anyone else. If it or another peptide fits your goals, we will say so, and if it does not, we will tell you that too.
FAQ
Frequently Asked Questions
Is tesamorelin FDA-approved?
Yes, for one use. Tesamorelin, sold as Egrifta, is FDA-approved to reduce excess abdominal fat in adults with HIV who have lipodystrophy. Prescribing it for other goals, such as general body composition or longevity, is off-label. A compounded tesamorelin is not FDA-approved at all, so ask your provider which product is being prescribed.
Is tesamorelin the same as HGH?
No. HGH is growth hormone given directly, while tesamorelin is a GHRH analog that signals your own pituitary gland to release growth hormone in its natural pulses. Both require careful medical supervision.
How is tesamorelin administered?
It is given as a small subcutaneous injection, typically self-administered at home after instruction from your care team. Protocols emphasize consistency, and your provider tailors the specifics to you based on your labs and goals.
How long does it take to see results with tesamorelin?
Response varies by individual and is not guaranteed. When changes occur, they generally develop gradually over weeks to months rather than immediately. Follow-up visits and repeat labs are used to track progress and adjust the plan over time.
Does tesamorelin help build muscle?
Tesamorelin was studied for visceral fat, not muscle building, and its trials did not show it to be a muscle-building drug. Raising growth hormone and IGF-1 can influence lean tissue, but any effect is individual and unproven for that purpose. Resistance training and adequate protein remain the reliable levers for muscle.
Does tesamorelin help with weight loss?
Tesamorelin is studied mainly for reducing visceral abdominal fat and supporting body composition, not as a general weight-loss drug. It is not a substitute for dedicated medical weight-loss therapies like semaglutide or tirzepatide. A provider can help determine whether it fits a broader, individualized plan.
Do I need lab work before starting tesamorelin?
Yes. A responsible peptide protocol begins with a consultation and baseline labs so your clinician can screen for contraindications and set a starting point. Periodic follow-up labs, including IGF-1 and metabolic markers, help monitor safety and response over time.
Can tesamorelin be prescribed through telehealth?
In many cases, hormone and longevity care can be delivered through telehealth in New York, New Jersey, Connecticut, Florida and California, though appropriate labs and provider evaluation are still required. Protocol Health offers tesamorelin through clinician-supervised care when appropriate, with in-person visits in Scarsdale and telehealth options depending on your needs.
Explore